Anti-HLA antibodies in double umbilical cord blood transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 11, 2011, Pages 1704-1708

  Brunstein, Claudio G ^a,b   Noreen, Harriet ^a   DeFor, Todd E ^a   Maurer, David ^a   Miller, Jeffrey S ^a,b   Wagner, John E ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Engraftment; Graft rejection; Unit predominance

Indexed keywords

CYCLOSPORIN; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; FEMALE; GRAFT RECIPIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; AGED; ANTIBODIES; COHORT STUDIES; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FETAL BLOOD; GRAFT REJECTION; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80054853536     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.04.013     Document Type: Article

References (11)

1. Gebel H.M., Bray R.A. Approaches for transplanting the sensitized patient: biology versus pharmacology. Nephrol Dial Transplant 2008, 23:2454-2457.
2. Ciurea S.O., de Lima M., Cano P., et al. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem cell transplantation. Transplantation 2009, 88:1019-1024.
3. Spellman S., Bray R., Rosen-Bronson S., et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood 2010, 115:2704-2708.
4. Takanashi M., Atsuta Y., Fujiwara K., et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood 2010, 116:2839-2846.
5. Takanashi M., Fujiwara K., Tanaka H., et al. The impact of HLA antibodies on engraftment of unrelated cord blood transplants. Transfusion 2008, 48:791-793.
6. Brunstein C.G., Barker J.N., Weisdorf D.J., et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007, 110:3064-3070.
7. Brunstein C.G., Gutman J.A., Weisdorf D.J., et al. Allogeneic hematopoietic cell transplantation for hematological malignancy: relative risks and benefits of double umbilical cord blood. Blood 2010, 116:4693-4699.
8. Ramirez P., Wagner J.E., DeFor T.E., et al. The kinetics of chimerism and factors that predict single unit predominance after double umbilical cord blood transplantation. Blood 2010, 116:105.
9. Lin D.Y. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997, 16:901-910.
10. Fine J.P., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
11. Gutman J.A., McKinney S.K., Pereira S., et al. Prospective monitoring for alloimmunization in cord blood transplantation: " virtual crossmatch" can be used to demonstrate donor-directed antibodies. Transplantation 2009, 87:415-418.